Hydroxychloroquine Chemoprophylaxis for COVID-19 Infection in High-risk Healthcare Workers

Burney et al., NCT04370015, NCT04370015, Oct 2020

HCQ for COVID-19

1st treatment shown to reduce risk in March 2020, now with p < 0.0000000001 from 426 studies, used in 59 countries.

No treatment is 100% effective.
Protocols combine treatments.

Estimated 374 participant HCQ prophylaxis RCT with results not reported over 6 years after estimated completion.
37 HCQ RCTs have results missing long after expected1-37
The trials report a total of 20,499 patients, with 12 trials having actual enrollment of 3,639, and the remainder estimated.
Burney et al., 15 Oct 2020, Double Blind Randomized Controlled Trial, placebo-controlled, trial NCT04370015 (history).